Renal biopsy: update
- PMID:15483458
- DOI: 10.1097/00041552-200411000-00013
Renal biopsy: update
Abstract
Purpose of review: The renal biopsy is an invaluable tool in the diagnosis, prognosis, and management of patients with kidney disease. As the success of the procedure is defined not only by the ability to obtain adequate tissue but also by the safety profile, significant advances which define risk factors and determine the optimal timing of observation after the percutaneous native renal biopsy merit discussion. Alternative methods of obtaining tissue, such as transvenous renal biopsies, have also been described, especially in patients with contraindications to the percutaneous method.
Recent findings: The percutaneous renal biopsy has been established as a safe and effective method of obtaining renal parenchyma. Complications, although rare, may occur and the majority of these are related to bleeding. The optimal timing of observation after the biopsy should be determined by when most complications occur, and, as over 33% of complications occur after 8 h, an observation period of at least 24 h is recommended. In patients with contraindications to the percutaneous approach, such as failure of adequate radiologic visualization or a bleeding diathesis, alternative methods of obtaining tissue have been attempted. These include open, laparascopic, transurethral, or transvenous renal biopsy.
Summary: Without contraindications, the percutaneous renal biopsy remains the standard method of acquiring renal tissue. At least 24 h of observation is recommended after the percutaneous native kidney biopsy for the development of potential complications. When a contraindication to the procedure exists, other methods of renal biopsy by experienced physicians may be attempted.
Similar articles
- Renal biopsy for medical renal disease: indications and contraindications.Bandari J, Fuller TW, Turner Іі RM, D'Agostino LA.Bandari J, et al.Can J Urol. 2016 Feb;23(1):8121-6.Can J Urol. 2016.PMID:26892051Review.
- Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications.Cluzel P, Martinez F, Bellin MF, Michalik Y, Beaufils H, Jouanneau C, Lucidarme O, Deray G, Grenier PA.Cluzel P, et al.Radiology. 2000 Jun;215(3):689-93. doi: 10.1148/radiology.215.3.r00ma07689.Radiology. 2000.PMID:10831685Clinical Trial.
- [Renal biopsy: procedures, contraindications, complications].Lefaucheur C, Nochy D, Bariety J.Lefaucheur C, et al.Nephrol Ther. 2009 Jul;5(4):331-9. doi: 10.1016/j.nephro.2009.02.005. Epub 2009 Apr 2.Nephrol Ther. 2009.PMID:19345174Review.French.
- Transjugular kidney biopsy: enabling safe tissue diagnosis in high risk patients.Levi IM, Ben-Dov IZ, Klimov A, Pizov G, Bloom AI.Levi IM, et al.Isr Med Assoc J. 2011 Jul;13(7):425-7.Isr Med Assoc J. 2011.PMID:21838185
- Percutaneous renal biopsy of the solitary kidney: a contraindication?Schow DA, Vinson RK, Morrisseau PM.Schow DA, et al.J Urol. 1992 May;147(5):1235-7. doi: 10.1016/s0022-5347(17)37526-2.J Urol. 1992.PMID:1569656Review.
Cited by
- Absorption fever characteristics due to percutaneous renal biopsy-related hematoma.Hu T, Liu Q, Xu Q, Liu H, Feng Y, Qiu W, Huang F, Lv Y.Hu T, et al.Medicine (Baltimore). 2016 Sep;95(37):e4754. doi: 10.1097/MD.0000000000004754.Medicine (Baltimore). 2016.PMID:27631225Free PMC article.
- The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study.Li C, Li P, Guo W, Chen L, Li J, Wang R, Chen B.Li C, et al.Korean J Intern Med. 2022 Jan;37(1):154-166. doi: 10.3904/kjim.2020.366. Epub 2021 Jul 22.Korean J Intern Med. 2022.PMID:32972118Free PMC article.
- Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy.Gal-Oz A, Papushado A, Kirgner I, Meirsdorf S, Schwartz D, Schwartz IF, Zubkov A, Grupper A.Gal-Oz A, et al.Ren Fail. 2020 Nov;42(1):10-18. doi: 10.1080/0886022X.2019.1700805.Ren Fail. 2020.PMID:31842662Free PMC article.
- Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis.Sargsyan SA, Serkova NJ, Renner B, Hasebroock KM, Larsen B, Stoldt C, McFann K, Pickering MC, Thurman JM.Sargsyan SA, et al.Kidney Int. 2012 Jan;81(2):152-9. doi: 10.1038/ki.2011.332. Epub 2011 Sep 28.Kidney Int. 2012.PMID:21956190Free PMC article.
- Measuring hemoglobin prior to early discharge without routine surveillance ultrasound after percutaneous native renal biopsy in children.Muthusami P, Sunder S, Gallibois C, Kitamura E, Parra D, Amaral J, John P, Noone D, Connolly B.Muthusami P, et al.Pediatr Nephrol. 2017 Oct;32(10):1927-1934. doi: 10.1007/s00467-017-3680-x. Epub 2017 May 5.Pediatr Nephrol. 2017.PMID:28477259
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials